, Plenary
Nominations for a committee Chair
I just wanted to second the nomination of Dai Rees MS.
, Health and Social Care Committee
NHS waiting times: evidence session with health bodies
Yes, of course. I'm happy, Chair. Thank you very much.
, Health and Social Care Committee
NHS waiting times: evidence session with health bodies
Thank you. I'm aware that we're short on time and I just wanted to ask another question that kind of follows on from that, if that's okay. We have mentioned the retention, but also, as you said, the future workforce does depend on trainees as well. As a…
, Health and Social Care Committee
NHS waiting times: evidence session with health bodies
That's really helpful to hear. Thank you. I was just going to move on to drill down a little bit more into it, because all of you have mentioned improving staff retention and how focusing on well-being and reducing workplace pressures is key to this. But you…
, Health and Social Care Committee
NHS waiting times: evidence session with health bodies
Thank you. Did anybody else want to come in? Sorry, I couldn't see anyone.
, Health and Social Care Committee
NHS waiting times: evidence session with health bodies
Thank you so much. And if I can just ask a follow-up question before others come in as well, based on what you've said. The Minister has highlighted workforce challenges in anaesthesia, ophthalmology and urology. Is that the right focus for the investment?…
, Health and Social Care Committee
NHS waiting times: evidence session with health bodies
Thank you very much, Chair. Thank you for being here today. Yes, that does follow on nicely, because I'm going to ask some questions now about workforce challenges. So, to start, could you tell the committee how satisfied you are with the actions being taken…
, Equality and Social Justice Committee
The public health approach to preventing gender-based violence: evidence session 7
Thank you very much. That's all my questions. Thank you, Chair.
, Equality and Social Justice Committee
The public health approach to preventing gender-based violence: evidence session 7
Thank you very much. I'll ask my last question then: to what extent are senior police leaders involved in revising the national VAWDASV indicators and reviewing progress in the implementation of the national training framework? They're both requirements of…
, Equality and Social Justice Committee
The public health approach to preventing gender-based violence: evidence session 7
Thank you very much. I'm going to ask my last question, and then—
, Equality and Social Justice Committee
The public health approach to preventing gender-based violence: evidence session 7
Thank you very much. That is very reassuring to hear, and you've also answered a number of my other questions at the same time, which is very helpful. I did just want to ask as well: with all of these cases in the media, though, and public trust has been…
, Equality and Social Justice Committee
The public health approach to preventing gender-based violence: evidence session 7
Thank you very much. I'm going to ask some questions now about senior leadership in the police, and, as we are overrunning, I'm going to get straight into it. Senior police leadership is key to making cultural changes inside the police service. What…
, Plenary
Topical Questions
Diolch, Minister. I know you and I were both appalled by the news last week of the possible closure of the Zimmer Biomet manufacturing factory in my constituency of Bridgend. Currently, the factory employs a total of 540 people from across Bridgend and the…
, Plenary
Topical Questions
1. Will the Minister make a statement in response to the announcement by Zimmer Biomet that it will cease manufacturing at its plant in Bridgend? TQ811
, Plenary
Questions to the First Minister
As the Member of the Senedd for Bridgend, I also want to raise the potential job losses at Zimmer Biomet in my constituency, and I also expressed my shock and extreme disappointment that there were no prior discussions to this announcement being made. I got a…
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Yes. I don't feel that anybody at that point is pretending that they're still in pain, are they? No, exactly. Absolutely. Thank you both very much, and thank you, Chair.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Absolutely. Thank you very much. My final question, then, is: you also say that women at the end of life can be prescribed sedatives, rather than appropriate pain relief and question the appropriateness of prescribing opiates to women. Are you aware of any…
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Thank you very much.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Thank you very much, Chair. Thank you all for being here today. I just have a couple of questions about pain management. So, in your paper, you say that women's pain is sometimes underestimated, partly due to gender bias. What evidence is there that women…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Okay, I'm going to hand back there. Thank you very much, both of you. I'm going to hand back there, though, Chair, because I think that, again, I'm pre-empting questions that are to come in the next section with one of my colleagues, who will drill down into…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
That is very positive news, thank you very much.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
That is to Helen, yes.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you very much for that, again. That brings me on to my final question: why isn't the data you collate and publish on gynaecological cancers disaggregated by each type—so, cervical, ovarian, endometrial, vulval and vaginal cancers? Can this be done? If…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Okay, thank you. That might be something that we can follow up in writing afterwards. Are you able to talk about the geographic pattern of cancer survival across Wales, then? Are there differences in cancer survival by health board?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you very much. That brings me on nicely to my next question, which is for Digital Health and Care Wales, so, Helen. Cancer survival estimates are the estimation of the proportion of patients surviving their cancer after one, five or 10 years, how…
